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Purpose
Since the introduction of antiretroviral therapy (ART) and the extension of life expectancy, HIV-infected persons have shown an
increasing number of cardiovascular events. The reduction of cardiovascular risk factors becomes a new challenge in HIV care.
One of the main objectives of the HIV&HEARTstudy is to examine the development of cardiovascular risk factors and treatment
of cardiovascular diseases.
Methods
This study is an on-going, prospective, regional multicentre trial that was conducted to analyse the frequency and clinical course
of cardiac disorders as well as cardiovascular risk factors in HIV-infected patients. 505 HIV-infected outpatients were recruited at
baseline (BL) and re-examined during 5-year follow up (5YFU).
Results
84% of 505 eligible HIV-infected patients were male. The average age was 44.399.5 years at BL. The proportion of ART-treated
patients increased from 85.7% at BL to 96.4% at 5YFU. During the 5-year observation period mean cardiovascular risk detected
by Framingham score increased from 6% at BL to 10% at 5YFU. Even after adjusting for age there was a difference in the
Framingham score of 2%. Between BL and 5YFU systolic blood pressure increased from 128.4919.8 mmHg to 138.3919.9
mmHg in spite of an intensified use of antihypertensive drugs, from 11.9% at BL to 24.0% at 5YFU.The rate of participants with
adiposity, characterised by a BMI 30, increased from 7.9% at BL to 11.2% at 5YFU. Lipid-lowering therapy was applied in
10.3% of the patients at BL and in 13.9% at 5YFU.Triglycerides (TAG)]200 mg/dl reduced from 38.9% at BL to 36.8% at 5YFU; in
contrast cholesterol values]200 mg/dl elevated from 57.8% to 61.8%. The same trend was observed in HDL540 mg/dl. Here
we found a change from 29.2% versus 31.3%. Doing regular sports elevated from 1.9% to 3.3%.The count of smokers increased
for 2.8% and also mean pack-years changes from 24 to 26.5 pack-years.
Conclusion
During a 5-year period the cardiovascular risk in Framingham score increased disproportionately high in this HIV-infected cohort
even after adjusting for age.There was an increasing blood pressure although an elevated use of antihypertensive therapy.There
was also a tendency of elevating BMI and an increasing trend in smoking behavior. As protective facts, we found a tendency in
doing sports and a decreasing TAG value during intensifying lipid-lowering therapy. Cardiovascular risk was increasing, in spite of
interventions.
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